Shivalik Rasayan Delivers Resilient Q4 With Dividend Boost

Shivalik Rasayan Limited posted consolidated income from operations of ₹1.03 billion and net profit of ₹45.3 million for the March 2026 quarter, reflecting resilience across its agrochemicals and pharma businesses. The company also announced a final dividend of 10% and key board-level changes.  

The company’s Q4 FY26 performance highlights a balanced revenue mix, with agrochemicals continuing to anchor topline growth while pharma formulations added momentum. Despite rising costs, Shivalik maintained profitability and strengthened its asset base, underscoring operational efficiency and strategic expansion.  

Revenue Performance

Profit And Dividend

Governance Updates

Key highlights  

• Consolidated revenue ₹1.03 billion in Q4 FY26  
• Net profit ₹45.3 million  
• EPS at ₹2.87  
• Dividend of 10% (₹0.50 per share)  
• Agrochemicals revenue ₹344.4 million  
• Pharma formulations revenue ₹606.4 million  
• Board reconstitution and auditor appointments  
  
  

Sources: Company filing, Shivalik Rasayan Limited Q4 FY26 results